Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 3—March 2017
Research

Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA

Jennifer AdjemianComments to Author , Timothy B. Frankland, Yihe G. Daida, Jennifer R. Honda, Kenneth N. Olivier, Adrian Zelazny, Stacey Honda, and D. Rebecca Prevots
Author affiliations: United States Public Health Service, Commissioned Corps, Rockville, Maryland, USA (J. Adjemian); National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA (J. Adjemian, A. Zelazny, D.R. Prevots); Kaiser Permanente, Honolulu, Hawaii, USA (T.B. Frankland, Y.G. Daida, S. Honda); University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA (J.R. Honda); National Jewish Health, Denver, Colorado, USA (J.R. Honda); National Heart, Lung, and Blood Institute, Bethesda (K.N. Olivier)

Main Article

Table 2

Occurrence of selected co-morbid conditions among Kaiser Permanente Hawaii patients who had mycobacterial cultures performed, Hawaii, 2005–2013*

Co-morbidity No. (%)
Total, n = 2,197† NTM isolated
 NTMPD, n = 254 TB, n = 40 Culture negative, n = 1,707
NTM, n = 455 MAC, n = 290 M. abscessus, n = 87 M. fortuitum, n = 109
COPD 780 (36) 188 (41) 130 (45) 33 (38) 39 (36) 108 (43) 5 (13) 588 (34)
Bronchiectasis 335 (15) 169 (37) 114 (39) 50 (58) 34 (31) 113 (44) 1 (3) 165 (10)
Cystic fibrosis 4 (0.2) 2 (0.4) 1 (0.3) 1 (1) 0 (0) 2 (0.8) 0 (0) 2 (0.1)
HIV 24 (1) 4 (0.9) 3 (1) 0 (0) 1 (0.9) 4 (2) 0 (0) 20 (1)
Coccidiomycosis 12 (0.6) 4 (0.9) 2 (0.7) 0 (0) 1 (0.9) 1 (0.4) 0 (0) 8 (0.5)
Sarcoidosis 10 (0.5) 3 (0.7) 2 (0.7) 0 (0) 1 (0.9) 0 (0) 0 (0) 7 (0.4)
Malignant neoplasm of trachea, bronchus, or lung 472 (21) 56 (12) 34 (12) 8 (9) 12 (11) 27 (11) 0 (0) 416 (24)
Other malignancies 453 (21) 92 (20) 62 (21) 16 (18) 20 (18) 52 (20) 5 (13) 357 (21)

*COPD, chronic obstructive pulmonary disease; MAC, Mycobacterium avium complex; NTM, nontuberculous mycobacteria; NTMPD, NTM pulmonary disease; TB, tuberculosis.
†Total number and percentage of patients with co-morbidity out of all Kaiser Permanente Hawaii patients with pulmonary mycobacterial culture results.

Main Article

Page created: February 17, 2017
Page updated: February 17, 2017
Page reviewed: February 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external